DSM based in Holland reported on second quarter results on August 5th.  Revenue attained $2,664 million, two percent lower than in Q2 of FY 2019.  The Nutrition Segment including vitamins and feed additives for human and livestock attained sales of $1,962 million, nine percent higher than the corresponding quarter of 2019.  In compliance with EU reporting convention, DSM provided EBITDA data with the nutrition segment contributing $417 million, eight percent higher than Q2 of fiscal 2019.

During the quarter, DSM announced the acquisition of Biomin and Romer from the Erber Group of Austria for $1,166 million.

Co-CEOs Geraldine Matchett and Dimitri de Vreece noted, “Our Teams continue to successfully navigate the challenging global environment with Q2 developments in-line with the expectations we set out in May.  Business conditions for Nutrition were good overall during the first half, with spikes in demand for animal nutrition in Q1 and human nutrition in Q2 as markets reacted in response to COVID-19.

DSM reiterated the full year outlook for 2020 despite considerable uncertainty regarding COVID-19 and its global effects.